Chase Investment Counsel’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $484K | Buy |
4,680
+63
| +1% | +$5.62K | 0.1% | 101 |
|
|
2026
Q1 | $331K | Buy |
4,617
+51
| +1% | +$3.93K | 0.09% | 126 |
|
|
2025
Q4 | $362K | Buy |
4,566
+364
| +9% | +$28.7K | 0.1% | 107 |
|
|
2025
Q3 | $316K | Buy |
+4,202
| New | +$288K | 0.09% | 112 |
|
|
2022
Q1 | – | Sell |
-5,061
| Closed | -$522K | – | 118 |
|
|
2021
Q4 | $522K | Buy |
5,061
+43
| +0.9% | +$3.97K | 0.21% | 68 |
|
|
2021
Q3 | $425K | Hold |
5,018
| – | – | 0.18% | 68 |
|
|
2021
Q2 | $418K | Hold |
5,018
| – | – | 0.17% | 73 |
|
|
2021
Q1 | $377K | Sell |
5,018
-13,675
| -73% | -$996K | 0.17% | 78 |
|
|
2020
Q4 | $1.28M | Sell |
18,693
-13,994
| -43% | -$910K | 0.56% | 52 |
|
|
2020
Q3 | $1.91M | Buy |
32,687
+13,910
| +74% | +$866K | 0.95% | 45 |
|
|
2020
Q2 | $1.22M | Buy |
18,777
+14,613
| +351% | +$920K | 0.62% | 53 |
|
|
2020
Q1 | $247K | Hold |
4,164
| – | – | 0.17% | 59 |
|
|
2019
Q4 | $309K | Buy |
4,164
+225
| +6% | +$15.8K | 0.16% | 92 |
|
|
2019
Q3 | $248K | Hold |
3,939
| – | – | 0.13% | 95 |
|
|
2019
Q2 | $214K | Hold |
3,939
| – | – | 0.11% | 94 |
|
|
2019
Q1 | $212K | Buy |
+3,939
| New | +$243K | 0.11% | 95 |
|
|
2018
Q4 | – | Sell |
-4,364
| Closed | -$343K | – | 98 |
|
|
2018
Q3 | $343K | Buy |
4,364
+504
| +13% | +$36K | 0.18% | 71 |
|
|
2018
Q2 | $248K | Buy |
3,860
+75
| +2% | +$4.94K | 0.13% | 75 |
|
|
2018
Q1 | $235K | Buy |
+3,785
| New | +$272K | 0.12% | 75 |
|
|
2017
Q4 | – | Sell |
-3,470
| Closed | -$282K | – | 83 |
|
|
2017
Q3 | $282K | Hold |
3,470
| – | – | 0.15% | 70 |
|
|
2017
Q2 | $279K | Hold |
3,470
| – | – | 0.14% | 74 |
|
|
2017
Q1 | $272K | Buy |
+3,470
| New | +$277K | 0.13% | 73 |
|
|
2016
Q4 | – | Sell |
-29,610
| Closed | -$2.63M | – | 96 |
|
|
2016
Q3 | $2.63M | Sell |
29,610
-31,273
| -51% | -$2.95M | 1.16% | 37 |
|
|
2016
Q2 | $5.83M | Sell |
60,883
-1,245
| -2% | -$124K | 2.58% | 12 |
|
|
2016
Q1 | $6.44M | Buy |
62,128
+350
| +0.6% | +$34K | 2.81% | 6 |
|
|
2015
Q4 | $6.04M | Sell |
61,778
-7,012
| -10% | -$687K | 2.41% | 11 |
|
|
2015
Q3 | $6.64M | Buy |
68,790
+558
| +0.8% | +$58.7K | 2.68% | 6 |
|
|
2015
Q2 | $7.16M | Sell |
68,232
-1,671
| -2% | -$171K | 2.6% | 4 |
|
|
2015
Q1 | $7.21M | Sell |
69,903
-4,395
| -6% | -$445K | 2.53% | 6 |
|
|
2014
Q4 | $7.16M | Buy |
74,298
+1,034
| +1% | +$91.1K | 2.55% | 4 |
|
|
2014
Q3 | $5.83M | Sell |
73,264
-1,140
| -2% | -$89.9K | 2.09% | 12 |
|
|
2014
Q2 | $5.61M | Buy |
74,404
+9,294
| +14% | +$702K | 1.9% | 18 |
|
|
2014
Q1 | $4.87M | Sell |
65,110
-13,940
| -18% | -$985K | 1.65% | 28 |
|
|
2013
Q4 | $5.66M | Sell |
79,050
-50,280
| -39% | -$3.23M | 1.67% | 28 |
|
|
2013
Q3 | $7.34M | Sell |
129,330
-39,970
| -24% | -$2.38M | 1.88% | 30 |
|
|
2013
Q2 | $9.68M | Buy |
+169,300
| New | +$9.81M | 2.58% | 6 |
|
Other funds holding CVS
Chase Investment Counsel's CVS Position: Q2 2026 in Review
Chase Investment Counsel increased its CVS Health (CVS) stake by 1.4% in Q2 2026, buying an estimated $5.62K and bringing the position to 4,680 shares worth $484K. The position accounts for 0.1% of the portfolio, ranked #101.
Chase Investment Counsel first reported a position in CVS in Q2 2013 and has held it in 36 quarters since. The position peaked at $9.68M in Q2 2013. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Chase Investment Counsel held 4,680 shares of CVS Health worth $484K as of Q2 2026.
- Chase Investment Counsel bought 63 CVS Health shares in Q2 2026, an estimated $5.62K.
- CVS Health made up 0.1% of Chase Investment Counsel's portfolio in Q2 2026, its #101 holding.
- Chase Investment Counsel first reported a position in CVS Health in Q2 2013 and has held it in 36 quarters since.
- Chase Investment Counsel's CVS Health position peaked at $9.68M in Q2 2013.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Chase Investment Counsel's 13F filing for Q2 2026, filed 6 Aug 2026.